Document is current

Any future updates will be listed below

158 Chemotherapy resistant gamma delta T-cell immunotherapy can leverage synergistic ligand expression through combinational chemotherapy and PARP-inhibitor use to enhance tumor cell recognition & killing

Crossref DOI link: https://doi.org/10.1136/jitc-2021-SITC2021.158

Published Online: 2021-11-10

Published Print: 2021-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark